Bahrain government delegation heads to Israel on Gulf Air flight: flight radar
DUBAI (Reuters) – Bahrain’s first official government delegation headed to Israel on Wednesday on the first Gulf Air commercial flight to Tel Aviv, as the two countries look to broaden cooperation after establishing formal ties in September in a U.S.-brokered accord.
Gulf Air flight GF972 – a reference to Israel’s country telephone code – took off from Manama airport Wednesday morning heading to Tel Aviv, according to flight tracking website FlightRadar24.
Victor Glemaud to Offer E-commerce for Curve Sizes
The home page of Glemaud.com featuring curve looks.
Victor Glemaud courtesy shot.
Fresh Express Kit Caesar Supreme Recalled For E. Coli Concerns
Fresh Express is recalling expired Fresh Express Kit Caesar Supreme for potential contamination with Escherichia coli STEC 026 bacteria, according to the U.S. Food and Drug Administration.
The recall involves a limited number of cases of 10.5 oz. Fresh Express Kit Caesar Supreme with the Use-by Date of November 8, and Product Code S296. The recalled product was distributed primarily in Western and Southwestern U.S. states.
The product is now 9 days past the Use-By Date, but it may still be in stores or consumers’ homes.
According to the agency, a single randomly selected package of 10.5 oz. Fresh Express Kit Caesar Supreme yielded a positive result for E. coli STEC 026.
However, no illnesses are reported, and the company has not received any consumer complaints in association with this recall.
No other Fresh Express products are subject to recall.
E. coli STEC 026 can cause diarrhea, severe stomach cramps and vomiting. Most people recover within a week, but some illnesses can last longer and can be more severe.
Consumers who may still have the expired product at home in their refrigerators should discard and not consume it. Refunds are also available where purchased.
In similar incidents, Tanimura & Antle Inc. in early November has recalled its packaged single head romaine lettuce, citing possible contamination with E. Coli 0157:H7.
BoE Chief Urges Banks, Regulators To Help Businesses To Raise Investment
Bank of England Governor Andrew Bailey said regulators and financial service firms must work together so businesses are able to get the finance they need to invest for the future.
At the CityUK National Conference, held on Tuesday, Bailey talked about the long-term effects of Covid-19 and the investment required to support the recovery.
Heightened uncertainty about the future tends to have negative effect on investment. Both Covid and the process of setting the future relationship with the EU have increased uncertainty, he noted.
Since the release of the Monetary Policy Report, there have been encouraging news on the vaccine front.
“If we can now see some light at the end of the tunnel, we need to focus more on important questions about how our economies will look in the future, how we want them to look, what will be the legacy of Covid, and what we can do to support and prioritise any necessary more structural changes,” said Bailey.
He observed that while there appears to be no shortage of aggregate saving, investment is weak in the UK.
As well as maintaining interest rates which are consistent with achieving the inflation target, quantitative easing at a time like this can prevent an unwarranted tightening in financial conditions, Bailey said.
“At the Bank, we are emphasising work on the supply of finance for productive investment, which is important for long-term growth and for financial stability,” the governor added.
Sanofi: Rilzabrutinib Granted Fast Track Designation – Quick Facts
Sanofi (SNYNF,SNY) said the U.S. FDA has granted Fast Track Designation to the oral investigational Bruton’s tyrosine kinase inhibitor, rilzabrutinib for the treatment of immune thrombocytopenia. The company noted that a phase 3 study evaluating rilzabrutinib for ITP has been initiated. Rilzabrutinib received orphan drug designation for the treatment of immune thrombocytopenia in October 2018.
Rilzabrutinib is an oral, reversible covalent, Bruton’s tyrosine kinase inhibitor being investigated for the treatment of immune mediated diseases. It is being investigated in a phase 3 trial for pemphigus.
European Shares Extend Gains On Vaccine Optimism
European stocks rose for the third straight session on Wednesday as growing hopes that a Covid-19 vaccine is within reach helped investors shrug off concerns regarding the tightening of measures amid the second wave of infections sweeping through Europe.
The pan European Stoxx 600 rose half a percent to 386.39 after rising 0.9 percent in the previous session. The German DAX edged up 0.2 percent, France’s CAC 40 index rose 0.1 percent and the U.K.’s FTSE 100 was up 0.6 percent.
Dutch bank ABN Amro lost 4 percent. The lender issued a cautious outlook after reporting its lowest income from lending in six years.
Informa gave up 3 percent. The British business information and events company said it is on track to deliver positive free cash flow from early 2021, with over £1bn of available liquidity.
Real estate investment trust Workspace Group tumbled 3.4 percent. After reporting an interim loss, the company has deferred a decision on dividend payment until the full-year.
BAE Systems rose over 2 percent. The defense giant said it expects its business to continue growing under the Joe Biden administration.
Continental AG declined 2.2 percent. The German automotive parts manufacturing company announced a new outlook for fiscal 2020 based on certain assumptions.
Bechtle shares soared 13 percent. The information technology company raised its FY20 earnings view after reporting a rise in Q3 profit.
Cable and harnessing manufacturing firm Leoni slumped 3.2 after it posted a third quarter net loss of 52 million euros.